Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

82.39
-2.5200-2.97%
Post-market: 82.04-0.3517-0.43%18:58 EDT
Volume:1.60M
Turnover:130.75M
Market Cap:11.61B
PE:-36.08
High:83.76
Open:83.13
Low:80.75
Close:84.91
52wk High:95.49
52wk Low:22.73
Shares:140.86M
Float Shares:122.00M
Volume Ratio:1.57
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:24.93
PE(LYR):-6,757.16

Loading ...

Arrowhead Pharma Acquires FDA Rare Pediatric Disease Priority Review Voucher

Reuters
·
Aug 05

Earnings Flash (ARWR) Arrowhead Pharmaceuticals Posts Fiscal Q3 Loss $1.36, vs. FactSet Est of $1.28 Loss

MT Newswires Live
·
Aug 05

Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth

Reuters
·
Aug 05

Arrowhead Net Loss Widens to $194.28 Million in FY26 Q3; Revenue Rises to $75.25 Million

Reuters
·
Aug 05

Arrowhead Pharma Q3 EPS $(1.36) Misses $(1.32) Estimate, Sales $75.253M Beat $54.294M Estimate

Benzinga Earnings
·
Aug 05

Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results

THOMSON REUTERS
·
Aug 05

Arrowhead Pharmaceuticals Q3 EPS USD -1.36

THOMSON REUTERS
·
Aug 05

Arrowhead Pharmaceuticals Q3 Operating Income USD -170.093 Million

THOMSON REUTERS
·
Aug 05

Arrowhead Pharmaceuticals - to Use Voucher for Plozasiran Snda in Severe Hypertriglyceridemia Before End of 2026

THOMSON REUTERS
·
Aug 05

Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher

THOMSON REUTERS
·
Aug 05

Arrowhead Pharma Grants 112,794 Inducement RSUs to 95 New Hires

Reuters
·
Aug 04

Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 04

The Bull Case For Arrowhead Pharmaceuticals (ARWR) Could Change Following Plozasiran’s Phase 3 Success And Zodasiran Milestone

Simply Wall St.
·
Aug 03

B. Riley Adjusts Arrowhead Pharmaceuticals Price Target to $123 From $101, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Arrowhead Pharmaceuticals : B. Riley Raises Target Price to $123 from $101

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30

RBC Raises Price Target on Arrowhead Pharmaceuticals to $100 From $87, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Jul 29

Arrowhead Pharmaceuticals : RBC Raises Target Price to $100 from $87

THOMSON REUTERS
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Earning Preview: Arrowhead Pharmaceuticals Q3 revenue is expected to increase by 129%, and institutional views are bullish

Earnings Agent
·
Jul 29